🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 47 of 99

  1. HB0017

    Huabo Biopharm Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  2. HB0056

    Shanghai University of Traditional Chinese Medicine

    Healthy

    phase 1 small molecule active

    1 trial

  3. HBS-201

    Harmony Biosciences Holdings

    Narcolepsy

    phase 1 small molecule completed

    1 trial

  4. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  5. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  6. HBV mRNA vaccine

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  7. HD204

    Prestige Biopharma Belgium

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. HEC 68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  9. HEC-007 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule active

    1 trial

  10. HEC-151 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  11. HEC113995

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  12. HEC113995 PA•H2O tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  13. HEC113995PA•H2O tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  14. HEC116094

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Influenza

    phase 1 small molecule completed

    1 trial

  15. HEC122505MsOH

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  16. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  17. HEC30654AcOH capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  18. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  19. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hemodialysis

    phase 1 small molecule completed

    1 trial

  20. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  21. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  22. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

  23. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  24. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  25. HEC83518

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  26. HEC83518 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  27. HEC89736

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Relapsed or Refractory B-cell Hematologic Malignancies

    phase 1 small molecule terminated

    1 trial

  28. HEC93077

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 small molecule completed

    1 trial

  29. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  30. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non-alcoholic Fatty Liver Disease

    phase 1 small molecule completed

    1 trial

  31. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial

  32. HER-2/neu peptide vaccine

    Marker Therapeutics

    HER2-positive Breast Cancer

    phase 1 mab completed

    1 trial

  33. HER2 Tumor Vaccine

    The First People's Hospital of Lianyungang

    Adenocarcinoma - GEJ

    phase 1 mab active

    1 trial

  34. HER3-DXd

    Daiichi Sankyo

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  35. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  36. HIV-1 C4-V3 Polyvalent Peptide Vaccine

    Praxis Precision Medicines

    HIV Infections

    phase 1 mab completed

    1 trial

  37. HIV-1 Peptide Vaccine, Microparticulate Monovalent

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  38. HMPL-306

    Hutchison Medipharma Limited

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  39. HMS5552

    Hua Medicine Limited

    Type II Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  40. HN2301 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  41. HN2302 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Disease

    phase 1 small molecule active

    1 trial

  42. HPV-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 1 mab active

    1 trial

  43. HRG80™ Red Ginseng + gamma cyclodextrin

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Absorption

    phase 1 other on hold

    1 trial

  44. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  45. HRT, DHEA and herb

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Irregular Menses

    phase 1 small molecule completed

    1 trial

  46. HS-10345 84mg

    Jian Li

    Treatment Resistant Depressive Disorder

    phase 1 small molecule completed

    1 trial

  47. HS-10382(Part 1: Dose escalation)

    Jian Li

    CML, Chronic Phase

    phase 1 small molecule active

    1 trial

  48. HS-IT101 Injection

    Qingdao University

    Solid Tumor

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.